OliX PharmaceuticalsInc Capital Reinvestment Ratio
Latest as of September 2025:
0.19x
OliX PharmaceuticalsInc capital reinvestment ratio. OliX PharmaceuticalsInc (226950) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩3.23 Billion) in capital expenditures (₩623.14 Million). See how much free cash does OliX PharmaceuticalsInc generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.19x
Capex / Operating Cash Flow
Operating Cash Flow
₩3.23 Billion
KRW
Capital Expenditures
₩623.14 Million
KRW
Data as of
Sep 2025
Most recent filing
OliX PharmaceuticalsInc Capital Reinvestment Ratio by Year (None–None)
OliX PharmaceuticalsInc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see OliX PharmaceuticalsInc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow